Duration of response to second-line, platinum-based chemotherapy for ovarian cancer: implications for patient management and clinical trial design (Q80396736)
Jump to navigation
Jump to search
scientific article published on 01 August 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Duration of response to second-line, platinum-based chemotherapy for ovarian cancer: implications for patient management and clinical trial design |
scientific article published on 01 August 2004 |
Statements
Duration of response to second-line, platinum-based chemotherapy for ovarian cancer: implications for patient management and clinical trial design (English)
Maurie Markman
Jonathan Markman
Kenneth Webster
Kristine Zanotti
Barbara Kulp
Gertrude Peterson
Jerome Belinson